The business described offers a unique asset in the form of a meticulously curated regulatory ingredient database, featuring 501 entries from reputable regulatory bodies such as the FDA, EFSA, FSANZ, WHO, UK FSA, and Health Canada. Each entry is supported by citations, making it a hard-to-replicate resource. Unlike competitors, their platform employs a deterministic and auditable scoring engine ensuring consistent results, free from AI-induced drift. The solution addresses a significant market gap by focusing on regulatory standards in regions like Australia, diverging from the EU/US-centric approach of significant peers. The platform is fully operational and includes features like a live demo web app, extensive automated testing, and mobile compatibility. Its AI system autonomously updates the database, streamlining maintenance and ensuring regulatory compliance. Monetization avenues are outlined, including a consumer app, B2B licensing options, and standalone dataset licensing. With no active monetization or user base, the business awaits a new owner to launch and promote these solutions. Operations involve minimal maintenance, with oversight primarily focused on approving regulatory updates. The solution targets health-conscious consumers in Australia and the US, as well as various nutrition and compliance-focused businesses. The price reflects the value of the assets, not financial performance, as the company is pre-revenue. The sale includes all necessary resources for continued development and operation, such as source code and documentation, alongside support for a seamless transition. The founder seeks a buyer capable of scaling the venture.